CommercialCoverageMedium impact
11.02.26c, Percutaneous Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation
Independence Blue Cross·Cardiology, Cardiothoracic Surgery·Medical Policy
Effective date
Apr 1, 2026
We identified it
Jun 19, 2026
Summary
Policy 11.02.26c regarding Percutaneous Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation has been reissued for commercial plans. This is a reissue of an existing policy with an effective date of April 1, 2026.
Action Required
By April 1, 2026: Billing team must review the updated policy 11.02.26c for percutaneous left atrial appendage closure devices at https://medpolicy.ibx.com/ibc/Commercial/Pages/Site-Activity-View.aspx to identify any changes in coverage criteria, prior authorization requirements, or billing guidelines. Update internal procedures and staff training accordingly for cardiology procedures involving atrial fibrillation stroke prevention devices.